Literature DB >> 1866341

Variations in local PGE levels: a potential factor in therapeutic responsiveness?

C Hammerman1, R Arcilla, K C Bui.   

Abstract

It was hypothesized that it is the concentration of PGE in the plasma which actually reaches the ductus arteriosus which determines ductal response to PGE administration. Therefore, site specific PGE levels were studied in two infants with ductus dependent congenital heart lesions who were receiving PGE1 infusions. PGE levels were found to vary in a fashion related to the infusion site and the specific cardiac anatomy and hemodynamics of each patient. One of our patients, for instance, had a double outlet right ventricle with high pulmonary vascular resistance and right to left ductal shunting. This infant was given an intraarterial infusion of PGE. The plasma concentrations of PGE in the ductal blood of the infant were negligible. Assuming that ductal site specific PGE levels are critical in mediating the therapeutic response, hemodynamics and infusion site are factors that should be considered when initiating a PGE infusion, or in evaluating a therapeutic failure of PGE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866341     DOI: 10.1007/BF02238406

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  7 in total

1.  Differential in vivo pulmonary degradation of prostaglandins E1, B1, and A1.

Authors:  R P Robertson
Journal:  Am J Physiol       Date:  1975-01

2.  Administration of E-type prostaglandins in ductus-dependent congenital heart disease.

Authors:  E D Silove
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

3.  Role of prostaglandin E1 and E2 in the management of neonatal heart disease.

Authors:  P M Olley; F Coceani; R D Rowe
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

4.  Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.

Authors:  M D Freed; M A Heymann; A B Lewis; S L Roehl; R C Kensey
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

5.  Failure of clinical response to prostaglandin E1 in a cyanotic infant with congenital absence of the ductus arteriosus.

Authors:  W T Hamilton; S J Lacina; S Bharati; M Lev; R A Arcilla
Journal:  Cathet Cardiovasc Diagn       Date:  1982

6.  E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.

Authors:  P M Olley; F Coceani; E Bodach
Journal:  Circulation       Date:  1976-04       Impact factor: 29.690

7.  Hypoxic vs septic pulmonary hypertension. Selective role of thromboxane mediation.

Authors:  C Hammerman; K Komar; H Abu-Khudair
Journal:  Am J Dis Child       Date:  1988-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.